Bridgeway Capital Management’s Biostage, Inc. Common Stock BSTG Stock Holding History

Bridgeway Capital Management’s Portfolio BSTG Stock Details BSTG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-28,525	Closed	-$41K	–	1568
2015 Q2	$41K	Sell	28,525 -21,754	-43%	-$53.3K	﹤0.01%	1476
2015 Q1	$163K	Hold	50,279	–	–	﹤0.01%	1359
2014 Q4	$160K	Hold	50,279	–	–	﹤0.01%	1338
2014 Q3	$407K	Hold	50,279	–	–	0.01%	1180
2014 Q2	$525K	Hold	50,279	–	–	0.01%	1067
2014 Q1	$456K	Hold	50,279	–	–	0.01%	1120
2013 Q4	$239K	Buy	+50,279	New	+$235K	0.01%	1265

Other funds holding BSTG

State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

WIC

Woodmont Investment Counsel Nashville, Tennessee $1.62B AUM 18.92% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Bridgeway Capital Management's BSTG Position: Q3 2015 in Review

Bridgeway Capital Management sold out of Biostage, Inc. Common Stock (BSTG) in Q3 2015, closing a stake of 28,525 shares — an estimated $41K sold.

Bridgeway Capital Management first reported a position in BSTG in Q4 2013 and held it in 7 quarters. The position peaked at $525K in Q2 2014. 30 funds tracked by Wall St. Rank hold BSTG as of Q3 2015.

Bridgeway Capital Management reported no remaining Biostage, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
Bridgeway Capital Management sold 28,525 Biostage, Inc. Common Stock shares in Q3 2015, an estimated $41K.
Bridgeway Capital Management first reported a position in Biostage, Inc. Common Stock in Q4 2013 and held it in 7 quarters.
Bridgeway Capital Management's Biostage, Inc. Common Stock position peaked at $525K in Q2 2014.
30 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q3 2015.

Based on Bridgeway Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.